No open-market selling at Conexeu Sciences Inc. in the past year, which is unusual. Instead one company insiders added about $162,000 worth of CNXU.
Purcell Lynn Sebastian (Director) made the biggest buy, worth around $162,000.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. 8 investment managers listed CNXU in their latest 13F filings (Q2 2026); more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Purcell Lynn Sebastian | Director | Buy | 202,500 | $0.80 | $162K | SEC |
In the last 12 months Conexeu Sciences Inc. insiders made open-market purchases worth about $162,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CNXU was filed on 2026-06-23.
8 investment managers reported holding CNXU in SEC Form 13F filings for Q2 2026.
No congressional trades in CNXU were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).